|
Outcomes of pediatric patients who relapse after first HCT for acute leukemia or MDS |
Mar 2021 |
Bone Marrow Transplantation |
Myelodysplastic Syndromes (MDS) |
|
PNH Phenotypes and Their Genesis |
Jun 2020 |
British Journal of Haematology |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
Paroxysmal nocturnal haemoglobinuria (PNH): novel therapies for an ancient disease |
Nov 2020 |
British Journal of Haematology |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
In Search for a Haemoglobin Threshold in Myelodysplastic Syndromes |
Jun 2020 |
British Journal of Haematology |
Myelodysplastic Syndromes (MDS) |
|
The evolving role of next generation sequencing in myelodysplastic syndromes |
Oct 2019 |
British Journal of Haematology |
Myelodysplastic Syndromes (MDS) |
|
Therapy-related myelodysplastic syndromes in the genomics era |
Jun 2023 |
Bulletin du Cancer |
Myelodysplastic Syndromes (MDS) |
|
Low participation rates and disparities in participation in interventional clinical trials for myelodysplastic syndromes |
Aug 2020 |
Cancer |
Myelodysplastic Syndromes (MDS) |
|
Good but not good enough: Clinical trial participation of patients with myelodysplastic syndromes |
Aug 2020 |
Cancer |
Myelodysplastic Syndromes (MDS) |
|
Alcohol use is not a significant contributor to myelodysplastic syndromes |
Apr 2020 |
Cancer Causes & Control : CCC |
Myelodysplastic Syndromes (MDS) |
|
Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS) |
Jan 2021 |
Cancer Causes & Control : CCC |
Myelodysplastic Syndromes (MDS) |
